Advertisement

Gestational Choriocarcinoma

Chapter
Part of the Current Clinical Pathology book series (CCPATH)

Abstract

Gestational choriocarcinoma is the most aggressive form of trophoblastic disease with tumor cells morphologically recapitulating the trophoblast of the developing placenta at its previllous stage. The tumor has a high propensity for hematogenous spread, and in fact, one of the most malignant tumors in human if untreated. Being a disease of long historical recognition (see Chap. 1), various names were used in the past including sarcoma uteri deciduocellulare as a malignant tumor derived from the decidua of pregnancy (Int J Gynecol Pathol 19(3):284–292, 2000), “deciduoma malignum” or “chorio-deciduo-cellular sarcoma,” “sarcoma of the chorial villi,” and “chorioepithelioma” (Int J Gynecol Pathol 19(3):284–292, 2000; Int J Gynecol Pathol 18(3):281–287, 1999). The term “choriocarcinoma” was eventually introduced by Ewing (J Hist Med Allied Sci 16:49–73, 1961; Surg Gynecol Obstet 10:26, 1910). The inception of chemotherapy management in late 1950s marked the beginning of the era of dramatic decrease in mortality of patients with gestational choriocarcinoma (Proc Soc Exp Biol Med 93:5, 1956). Once an invariably fatal malignancy, the tumor can be treated with over 90% survival or cure rate by methotrexate-based chemotherapy (Proc Soc Exp Biol Med 93:5, 1956; Am J Obstet Gynecol 82:631–640, 1961).

Keywords

Choriocarcinoma Diagnostic features Differential diagnosis 

References

  1. 1.
    Stewart CJ. History of gynecological pathology. VIII. John Hammond teacher. Int J Gynecol Pathol. 2000;19(3):284–92.PubMedCrossRefGoogle Scholar
  2. 2.
    Dallenbach-Hellweg G, Schmidt D. History of gynecological pathology. VI. Jacob Felix Marchand. Int J Gynecol Pathol. 1999;18(3):281–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Ober WB, Fass RO. The early history of choriocarcinoma. J Hist Med Allied Sci. 1961;16:49–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Ewing J. Chorioma. Surg Gynecol Obstet. 1910; 10:26.Google Scholar
  5. 5.
    Li MC, Hertz R, Spencer DB. Effect of methotrexate therapy upon choriocarcinoma and choriadenoma. Proc Soc Exp Biol Med. 1956;93:5.Google Scholar
  6. 6.
    Hertz R, Lewis Jr J, Lipsett MB. Five year’s experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol. 1961;82:631–40.PubMedGoogle Scholar
  7. 7.
    Horn LC, Bilek K. Clinicopathologic analysis of gestational trophoblastic disease – report of 158 cases. Gen Diagn Pathol. 1997;143(2–3):173–8.PubMedGoogle Scholar
  8. 8.
    Smith HO, Kohorn E, Cole LA. Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin North Am. 2005;32(4):661–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Ober WB, Edgcomb JH, Price Jr EB. The pathology of choriocarcinoma. Ann N Y Acad Sci. 1971; 172(10):299–426.PubMedCrossRefGoogle Scholar
  10. 10.
    Yingna S, Yang X, Xiuyu Y, Hongzhao S. Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. Gynecol Oncol. 2002;84(3):416–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Lurain JR, Casanova LA, Miller DS, Rademaker AW. Prognostic factors in gestational trophoblastic tumors: a proposed new scoring system based on multivariate analysis. Am J Obstet Gynecol. 1991;164(2):611–6.PubMedGoogle Scholar
  12. 12.
    O’Neill CJ, Houghton F, Clarke J, McCluggage WG. Uterine gestational choriocarcinoma developing after a long latent period in a postmenopausal woman: the value of DNA polymorphism studies. Int J Surg Pathol. 2008;16(2):226–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Okamoto T, Nomura S, Nakanishi T, Yamada S, Tomoda Y. A case of uterine choriocarcinoma with spontaneous rupture twenty-three years following the antecedent pregnancy. J Obstet Gynaecol Res. 1997; 23(2):189–95.PubMedGoogle Scholar
  14. 14.
    Marcu M, Chefani A, Sajin M. Postmenopausal choriocarcinoma: a case report. Rom J Morphol Embryol. 2005;46(2):145–8.PubMedGoogle Scholar
  15. 15.
    Desai NR, Gupta S, Said R, Desai P, Dai Q. Choriocarcinoma in a 73-year-old woman: a case report and review of the literature. J Med Case Reports. 2010;4(1):379.PubMedCrossRefGoogle Scholar
  16. 16.
    Bagshawe KD, Golding PR, Orr AH. Choriocarcinoma after hydatidiform mole. Studies related to effectiveness of follow-up practice after hydatidiform mole. Br Med J. 1969;3(5673):733–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Matsui H, Iizuka Y, Sekiya S. Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet. 1996;53(1):63–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Wong LC, Ma HK. The syndrome of partial mole. Arch Gynecol. 1984;234(3):161–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Looi LM, Sivanesaratnam V. Malignant evolution with fatal outcome in a patient with partial hydatidiform mole. Aust N Z J Obstet Gynaecol. 1981;21(1): 51–2.PubMedCrossRefGoogle Scholar
  20. 20.
    Heifetz SA, Czaja J. In situ choriocarcinoma arising in partial hydatidiform mole: implications for the risk of persistent trophoblastic disease. Pediatr Pathol. 1992;12(4):601–11.PubMedCrossRefGoogle Scholar
  21. 21.
    Medeiros F, Callahan MJ, Elvin JA, Dorfman DM, Berkowitz RS, Quade BJ. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol. 2008; 27(2):247–51.PubMedGoogle Scholar
  22. 22.
    Bagshawe KD, Lawler SD, Paradinas FJ, Dent J, Brown P, Boxer GM. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet. 1990;335(8697):1074–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Vejerslev LO, Larsen G, Jacobsen M. Partial hydatidiform mole with subsequent trophoblastic tumor; a case report. Eur J Obstet Gynecol Reprod Biol. 1991; 40(1):73–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000;356(9223):36–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Berkowitz RS, Goldstein DP, Bernstein MR. Choriocarcinoma following term gestation. Gynecol Oncol. 1984;17(1):52–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Detry O, Detroz B, D’Silva M, Pirenne J, Defraigne JO, Meurisse M, et al. Misdiagnosed malignancy in transplanted organs. Transpl Int. 1993;6(1):50–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Gokel JM, Rjosk HK, Meister P, Stelter WJ, Witte J. Metastatic choriocarcinoma transplanted with cadaver kidney: a case report. Cancer. 1977;39(3):1317–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Braun-Parvez L, Charlin E, Caillard S, Ducloux D, Wolf P, Rolle F, et al. Gestational choriocarcinoma transmission following multiorgan donation. Am J Transplant. 2010;10(11):2541–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Marsh Jr JW, Esquivel CO, Makowka L, Todo S, Gordon RD, Tzakis A, et al. Accidental transplantation of malignant tumor from a donor to multiple recipients. Transplantation. 1987;44(3):449–50.PubMedCrossRefGoogle Scholar
  30. 30.
    Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, et al. Transmission of donor cancer into ­cardiothoracic transplant recipients. Surgery. 2001; 130(4):660–6; discussion 6–8.Google Scholar
  31. 31.
    Azuma C, Saji F, Nobunaga T, Kamiura S, Kimura T, Tokugawa Y, et al. Studies on the pathogenesis of choriocarcinoma by analysis of restriction fragment length polymorphisms. Cancer Res. 1990;50(3):488–91.PubMedGoogle Scholar
  32. 32.
    Yap KL, Hafez MJ, Mao TL, Kurman RJ, Murphy KM, Shih Ie M. Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol. 2010;2010:364508.PubMedGoogle Scholar
  33. 33.
    Wake N, Tanaka K, Chapman V, Matsui S, Sandberg AA. Chromosome and cellular origin of choriocarcinoma. Cancer Res. 1981;41(8):3137–43.PubMedGoogle Scholar
  34. 34.
    Sheppard DM, Fisher RA, Lawler SD. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet. 1985;16(3):251–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Bettio D, Giardino D, Rizzi N, Simoni G. Cytogenetic abnormalities detected by direct analysis in a case of choriocarcinoma. Cancer Genet Cytogenet. 1993; 68(2):149–51.PubMedCrossRefGoogle Scholar
  36. 36.
    Rodriguez E, Melamed J, Reuter V, Chaganti RS. Chromosomal abnormalities in choriocarcinomas of the female. Cancer Genet Cytogenet. 1995;80(1):9–12.PubMedCrossRefGoogle Scholar
  37. 37.
    Ahmed MN, Kim K, Haddad B, Berchuck A, Qumsiyeh MB. Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma. Cancer Genet Cytogenet. 2000; 116(1):10–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Asanoma K, Kato H, Inoue T, Matsuda T, Wake N. Analysis of a candidate gene associated with growth suppression of choriocarcinoma and differentiation of trophoblasts. J Reprod Med. 2004;49(8):617–26.PubMedGoogle Scholar
  39. 39.
    Wake N, Arima T, Matsuda T. Involvement of IGF2 and H19 imprinting in choriocarcinoma development. Int J Gynaecol Obstet. 1998;60 Suppl 1:S1–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, et al. Loss of imprinting in choriocarcinoma. Nat Genet. 1995;9(2):109–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Brewer JI, Mazur MT. Gestational choriocarcinoma. Its origin in the placenta during seemingly normal pregnancy. Am J Surg Pathol. 1981;5(3):267–77.PubMedCrossRefGoogle Scholar
  42. 42.
    Ollendorff DA, Goldberg JM, Abu-Jawdeh GM, Lurain JR. Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta. Obstet Gynecol. 1990;76(3 Pt 2):494–7.PubMedGoogle Scholar
  43. 43.
    Flam F. Choriocarcinoma in the term placenta: a difficult diagnosis. Eur J Gynaecol Oncol. 1996;17(6): 510–1.PubMedGoogle Scholar
  44. 44.
    Chung C, Kao MS, Gersell D. Incidental placental choriocarcinoma in a term pregnancy: a case report. J Med Case Reports. 2008;2:330.PubMedCrossRefGoogle Scholar
  45. 45.
    Bower M, Brock C, Fisher RA, Newlands ES, Rustin GJ. Gestational choriocarcinoma. Ann Oncol. 1995; 6(5):503–8.PubMedGoogle Scholar
  46. 46.
    Bentley RC. Pathology of gestational trophoblastic disease. Clin Obstet Gynecol. 2003;46(3):513–22.PubMedCrossRefGoogle Scholar
  47. 47.
    Kairi-Vassilatou E, Papakonstantinou K, Grapsa D, Kondi-Paphiti A, Hasiakos D. Primary gestational choriocarcinoma of the uterine cervix. Report of a case and review of the literature. Int J Gynecol Cancer. 2007;17(4):921–5.PubMedCrossRefGoogle Scholar
  48. 48.
    Butler R, Chadha Y, Davies J, Singh M. A case of primary tubal gestational choriocarcinoma. Aust N Z J Obstet Gynaecol. 2010;50(2):200–1.PubMedCrossRefGoogle Scholar
  49. 49.
    Logani KB, Sharma S, Kohli TP, Khemani M, Prakash N. Gestational choriocarcinoma of the fallopian tube – a case report. Indian J Cancer. 1995;32(4):183–5.PubMedGoogle Scholar
  50. 50.
    Ober WB, Maier RC. Gestational choriocarcinoma of the fallopian tube. Diagn Gynecol Obstet. 1981;3(3): 213–31.PubMedGoogle Scholar
  51. 51.
    Chan DP, Wong WP. Extrauterine gestational choriocarcinoma. Report of two cases. Obstet Gynecol. 1970;35(5):730–3.PubMedGoogle Scholar
  52. 52.
    Maehama T, Uemura S, Higashi M, Kanazawa K, Unten K. A case of primary gestational ovarian choriocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi. 1996;48(6):427–30.PubMedGoogle Scholar
  53. 53.
    Patton Jr GW, Goldstein DP. Gestational choriocarcinoma of the tube and ovary. Surg Gynecol Obstet. 1973;137(4):608–12.PubMedGoogle Scholar
  54. 54.
    Rotas M, Khulpateea N, Binder D. Gestational choriocarcinoma arising from a cornual ectopic pregnancy: a case report and review of the literature. Arch Gynecol Obstet. 2007;276(6):645–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Veridiano NP, Gal D, Delke I, Rosen Y, Tancer ML. Gestational choriocarcinoma of the ovary. Gynecol Oncol. 1980;10(2):235–40.PubMedCrossRefGoogle Scholar
  56. 56.
    Mao TL, Kurman RJ, Huang CC, Lin MC, Shih Ie M. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007;31(11):1726–32.PubMedCrossRefGoogle Scholar
  57. 57.
    Driscoll SG. Choriocarcinoma: an “incidental finding” in a term placenta. Obstet Gynecol. 1963;21:96–101.Google Scholar
  58. 58.
    Liu J, Guo L. Intraplacental choriocarcinoma in a term placenta with both maternal and infantile metastases: a case report and review of the literature. Gynecol Oncol. 2006;103(3):1147–51.PubMedCrossRefGoogle Scholar
  59. 59.
    Sebire NJ, Lindsay I, Fisher RA, Seckl MJ. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol. 2005;24(1):21–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Zanetta G, Maggi R, Colombo M, Bratina G, Mangioni C. Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. Int J Gynecol Cancer. 1997;7(1):66–77.PubMedCrossRefGoogle Scholar
  61. 61.
    Barghorn A, Bannwart F, Stallmach T. Incidental choriocarcinoma confined to a near-term placenta. Virchows Arch. 1998;433(1):89–91.PubMedCrossRefGoogle Scholar
  62. 62.
    Ganapathi KA, Paczos T, George MD, Goodloe S, Balos LL, Chen F. Incidental finding of placental choriocarcinoma after an uncomplicated term pregnancy: a case report with review of the literature. Int J Gynecol Pathol. 2010;29(5):476–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Fox H, Laurini RN. Intraplacental choriocarcinoma: a report of two cases. J Clin Pathol. 1988;41(10): 1085–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Fukunaga M, Ushigome S, Ishikawa E. Chorio­carcinoma in situ: a case at an early gestational stage. Histopathology. 1995;27(5):473–6.PubMedCrossRefGoogle Scholar
  65. 65.
    Fukunaga M, Ushigome S. Malignant trophoblastic tumors: immunohistochemical and flow cytometric comparison of choriocarcinoma and placental site trophoblastic tumors. Hum Pathol. 1993;24(10): 1098–106.PubMedCrossRefGoogle Scholar
  66. 66.
    Fisher RA, Lawler SD, Povey S, Bagshawe KD. Genetically homozygous choriocarcinoma following pregnancy with hydatidiform mole. Br J Cancer. 1988;58(6):788–92.PubMedCrossRefGoogle Scholar
  67. 67.
    Chaganti RS, Koduru PR, Chakraborty R, Jones WB. Genetic origin of a trophoblastic choriocarcinoma. Cancer Res. 1990;50(19):6330–3.PubMedGoogle Scholar
  68. 68.
    Osada H, Kawata M, Yamada M, Okumura K, Takamizawa H. Genetic identification of pregnancies responsible for choriocarcinomas after multiple pregnancies by restriction fragment length polymorphism analysis. Am J Obstet Gynecol. 1991;165(3):682–8.PubMedGoogle Scholar
  69. 69.
    Fisher RA, Newlands ES, Jeffreys AJ, Boxer GM, Begent RH, Rustin GJ, et al. Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer. 1992;69(3):839–45.PubMedCrossRefGoogle Scholar
  70. 70.
    Suzuki T, Goto S, Nawa A, Kurauchi O, Saito M, Tomoda Y. Identification of the pregnancy responsible for gestational trophoblastic disease by DNA analysis. Obstet Gynecol. 1993;82(4 Pt 1):629–34.PubMedCrossRefGoogle Scholar
  71. 71.
    Vojtassak J, Repiska V, Zajac V, Konecna B, Korbel M, Danihel L. Origin of choriocarcinoma in previous molar pregnancy proved by DNA analysis. Neoplasma. 1996;43(1):57–9.PubMedGoogle Scholar
  72. 72.
    Fisher RA, Savage PM, MacDermott C, Hook J, Sebire NJ, Lindsay I, et al. The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies. Gynecol Oncol. 2007;107(3):413–9.PubMedCrossRefGoogle Scholar
  73. 73.
    Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18 Suppl 2:S61–79.PubMedCrossRefGoogle Scholar
  74. 74.
    Baker PM, Oliva E. Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. Int J Gynecol Pathol. 2005;24(1):39–55.PubMedGoogle Scholar
  75. 75.
    Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. J Reprod Med. 2002;47(6):445–50.PubMedGoogle Scholar
  76. 76.
    Kohorn EI. Gestational trophoblastic neoplasia and evidence-based medicine. J Reprod Med. 2002;47(6): 427–32.PubMedGoogle Scholar
  77. 77.
    Morgan JM, Lurain JR. Gestational trophoblastic neoplasia: an update. Curr Oncol Rep. 2008;10(6):497–504.PubMedCrossRefGoogle Scholar
  78. 78.
    Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, et al. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol. 2005;99(3):603–7.PubMedCrossRefGoogle Scholar
  79. 79.
    Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20(1):31–47.PubMedCrossRefGoogle Scholar
  80. 80.
    Vance RP, Geisinger KR. Pure nongestational choriocarcinoma of the ovary. Report of a case. Cancer. 1985;56(9):2321–5.PubMedCrossRefGoogle Scholar
  81. 81.
    Kong B, Tian YJ, Zhu WW, Qin YJ. A pure nongestational ovarian choriocarcinoma in a 10-year-old girl: case report and literature review. J Obstet Gynaecol Res. 2009;35(3):574–8.PubMedCrossRefGoogle Scholar
  82. 82.
    Park SH, Park A, Kim JY, Kwon JH, Koh SB. A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. J Gynecol Oncol. 2009;20(3):192–4.PubMedCrossRefGoogle Scholar
  83. 83.
    Ozdemir I, Demirci F, Yucel O, Demirci E, Alper M. Pure ovarian choriocarcinoma: a difficult diagnosis of an unusual tumor presenting with acute abdomen in a 13-year-old girl. Acta Obstet Gynecol Scand. 2004; 83(5):504–5.PubMedGoogle Scholar
  84. 84.
    Zhao J, Xiang Y, Wan XR, Feng FZ, Cui QC, Yang XY. Molecular genetic analyses of choriocarcinoma. Placenta. 2009;30(9):816–20.PubMedCrossRefGoogle Scholar
  85. 85.
    Lorigan PC, Grierson AJ, Goepel JR, Coleman RE, Goyns MH. Gestational choriocarcinoma of the ovary diagnosed by analysis of tumour DNA. Cancer Lett. 1996;104(1):27–30.PubMedCrossRefGoogle Scholar
  86. 86.
    Shigematsu T, Kamura T, Arima T, Wake N, Nakano H. DNA polymorphism analysis of a pure non-gestational choriocarcinoma of the ovary: case report. Eur J Gynaecol Oncol. 2000;21(2):153–4.PubMedGoogle Scholar
  87. 87.
    Tsujioka H, Hamada H, Miyakawa T, Hachisuga T, Kawarabayashi T. A pure nongestational chorio­carcinoma of the ovary diagnosed with DNA polymorphism analysis. Gynecol Oncol. 2003;89(3): 540–2.PubMedCrossRefGoogle Scholar
  88. 88.
    Yamamoto E, Ino K, Yamamoto T, Sumigama S, Nawa A, Nomura S, et al. A pure nongestational choriocarcinoma of the ovary diagnosed with short tandem repeat analysis: case report and review of the literature. Int J Gynecol Cancer. 2007;17(1):254–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Koo HL, Choi J, Kim KR, Kim JH. Pure non-­gestational choriocarcinoma of the ovary diagnosed by DNA polymorphism analysis. Pathol Int. 2006; 56(10):613–6.PubMedCrossRefGoogle Scholar
  90. 90.
    Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009;33(4):633–8.PubMedCrossRefGoogle Scholar
  91. 91.
    Singer G, Kurman RJ, McMaster MT, Shih Ie M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26(7):914–20.PubMedCrossRefGoogle Scholar
  92. 92.
    Acosta-Sison H. The relative frequency of various anatomic sites as the point of first metastasis in 32 cases of chorionepithelioma. Am J Obstet Gynecol. 1958;75(5):1149–52.PubMedGoogle Scholar
  93. 93.
    Tsukamoto N, Kashimura Y, Sano M, Saito T, Kanda S, Taki I. Choriocarcinoma occurring within the normal placenta with breast metastasis. Gynecol Oncol. 1981;11(3):348–63.PubMedCrossRefGoogle Scholar
  94. 94.
    Kodama S, Yoshiya N, Honma S, Yasuda M, Ikarashi H, Tanaka K. Choriocarcinoma in a term placenta with pulmonary metastasis. Asia Oceania J Obstet Gynaecol. 1994;20(4):367–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of PathologyYale University School of MedicineNew HavenUSA

Personalised recommendations